Kristine Peterson - Jun 16, 2021 Form 4 Insider Report for ImmunoGen, Inc. (IMGN)

Role
Director
Signature
/s/ Joseph J. Kenny, attorney in fact
Stock symbol
IMGN
Transactions as of
Jun 16, 2021
Transactions value $
$297,880
Form type
4
Date filed
6/17/2021, 04:22 PM
Previous filing
Jun 16, 2021
Next filing
Feb 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGN Deferred Share Unit Award $0 +15K +33.37% $0.00 60K Jun 16, 2021 Common Stock 15K $0.00 Direct F1, F2, F3
transaction IMGN Stock Option (right to buy) Award $298K +44K $6.77 44K Jun 16, 2021 Common Stock 44K $6.77 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis.
F2 The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors.
F3 The deferred share units vest quarterly on each of 9/1/21, 12/1/21, 3/1/22, and 6/1/22, contingent upon the individual remaining a director as of each vesting date.
F4 Exercisable as to 11,000 shares on each of 9/1/21, 12/1/21, 3/1/22 and 6/1/22, contingent upon the individual remaining a director as of each vesting date.